Table 1.
Neutralization (ID50) of subtype-A, B and C viruses by #254 plasma sample
| Sr. No. | Virus | Tier | Subtype | ID50 |
|---|---|---|---|---|
|
1 |
92RW009 |
1 |
A |
74 |
|
2 |
Q461 |
1 |
A |
98 |
|
3 |
SF162 |
1 |
B |
1296 |
|
4 |
JRCSF |
1 |
B |
103 |
|
5 |
Du156.12 |
2 |
C |
206 |
|
6 |
ZM53M.PB12 |
2 |
C |
<60 |
|
7 |
ZM109F.PB4 |
2 |
C |
104 |
|
8 |
JRFL |
2 |
B |
<60 |
|
9 |
RHPA4259.7 |
2 |
B |
446 |
| 10 | TRO.11 | 2 | B | 162 |
The cross neutralizing activities of plasma antibodies from HIV-1 infected drug naïve sample #254 against a panel of subtype-A, B, C tier 1 and 2 viruses indicated on left. The numerical values on the extreme right of table represent the mean 50% neutralization titers (ID50) defined as the reciprocal dilution of plasma which neutralized 50% of viral infection in the assay. For clarity, this information is coded; ID50> 1000 (Bold), ID50= 100-l000 (Bold Italic), ID50= 61–100 (Italic) and ID50<60, where 50% neutralization was not reached. Each experiment was performed at least two independent times and in duplicates.